Cencora COR 深 沪
交易中 11-11 11:02:05 美东时间
347.98
-0.730
-0.21%
华盛通- 最 高348.65
- 今 开345.975
- 成交量 12.31万股
- 最 低 345.55
- 昨 收 348.71
- 总市值 664.04亿
- 52周最高 375.74
- 市盈率 静 19.39
- 换手率 0.06%
- 52周最低 243.62
- 委 比 33.33%
- 总股本 1.91亿
- 历史最高 375.74
- 量 比 0.31
- 振 幅 0.89%
- 历史最低 -9.225
- 每 手 1
- 风险率 29.13%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行维持英伟达"超配"评级！但目标价从315美元降至300美元
今日重点评级关注：花旗：维持Faeth Therapeutics"买入"评级，目标价从55美元升至60美元；HC Wainwright & Co.：维持Ocular Therapeutix"买入"评级，目标价从25美元升至28美元
11-11 10:50
JP Morgan Maintains Overweight on Cencora, Raises Price Target to $413
JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $390 to $413.
11-11 00:40
Here’s How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 7.95% on an annualized basis producing an average annual return of 20.98%. Currently, Cencora has a market capitalization of $64.82 billion. Buying $1000 In COR: If an investor had bought $1000 of COR stock 10 years ago, it wou...
11-07 04:30
美股大行评级 | 可口可乐、麦当劳、3M等获多家大行看好；机构上调高通目标价至165美元
今日重点评级关注：Citizens：维持Precigen"跑赢大市"评级，目标价从11美元升至12美元；Leerink Partners：维持Arcus Biosciences"跑赢大市"评级，目标价从46美元升至49美元
11-06 16:15
Cencora Reports Revised Segment Information Following Operating Model Restructuring
Cencora ( ($COR) ) has issued an update. Cencora recently completed a restructu...
11-04 22:48
财报速睇 | Cencora 2026财年Q4营收883.55亿美元，同比增长5.5%；归母净利润12.49亿美元，同比增长22.1%
华盛资讯11月4日讯，Cencora公布2026财年Q4业绩，公司Q4营收883.55亿美元，同比增长5.5%，归母净利润12.49亿美元，同比增长22.1%。
11-04 22:47
财报速睇 | Cencora 2026财年Q3营收883.55亿美元，同比增长5.5%；归母净利润5.19亿美元，扭亏为盈
华盛资讯11月4日讯，Cencora公布2026财年Q3业绩，公司Q3营收883.55亿美元，同比增长5.5%，归母净利润5.19亿美元，扭亏为盈。
11-04 19:46
Cencora Sees FY2027 Adj EPS $19.40-$19.75 vs $19.70 Est; Sees Sales $347.519B-$354.267B vs $352.380B Est
Cencora (NYSE:COR) is looking for FY2027 Adj EPS of $19.40-$19.75 vs $19.70 analyst estimate. sees sales of $347.519 billion-$354.267 billion vs $352.380 billion analyst estimate.
11-04 19:38
ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test
ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber Technologies, CVS Health and Emerson Electric report before the open; Qualcomm, McKesson, MercadoLibre and...
11-04 04:31
美股大行评级 | 潜在涨幅332.55%！Viking Therapeutics获上调目标价至118美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至118美元；Canaccord Genuity：维持Aclaris Therapeutics"买入"评级，目标价从10美元升至13美元
11-02 18:53
